These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31015254)

  • 1. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
    Carofino BL; Ayanga B; Justice MJ
    Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
    Dettman EJ; Simko SJ; Ayanga B; Carofino BL; Margolin JF; Morse HC; Justice MJ
    Oncogene; 2011 Jun; 30(25):2859-73. PubMed ID: 21339739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.
    Tracey LJ; Justice MJ
    Trends Genet; 2019 Jul; 35(7):489-500. PubMed ID: 31130394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM14: a unique regulator for pluripotency and epigenetic reprogramming.
    Nakaki F; Saitou M
    Trends Biochem Sci; 2014 Jun; 39(6):289-98. PubMed ID: 24811060
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
    Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation.
    Nady N; Gupta A; Ma Z; Swigut T; Koide A; Koide S; Wysocka J
    Elife; 2015 Nov; 4():e10150. PubMed ID: 26523391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation.
    Okashita N; Sakashita N; Ito K; Mitsuya A; Suwa Y; Seki Y
    Biochem Biophys Res Commun; 2015 Oct; 466(1):138-45. PubMed ID: 26325469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-option of the PRDM14-CBFA2T complex from motor neurons to pluripotent cells during vertebrate evolution.
    Kawaguchi M; Sugiyama K; Matsubara K; Lin CY; Kuraku S; Hashimoto S; Suwa Y; Yong LW; Takino K; Higashida S; Kawamura D; Yu JK; Seki Y
    Development; 2019 Jan; 146(2):. PubMed ID: 30630825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency.
    Okashita N; Suwa Y; Nishimura O; Sakashita N; Kadota M; Nagamatsu G; Kawaguchi M; Kashida H; Nakajima A; Tachibana M; Seki Y
    Stem Cell Reports; 2016 Dec; 7(6):1072-1086. PubMed ID: 27866876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
    Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
    Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
    Ji J; Cao J; Chen P; Huang R; Ye SD
    J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.
    Carofino BL; Ayanga B; Tracey LJ; Brooke-Bisschop T; Justice MJ
    Biol Open; 2016 May; 5(5):645-53. PubMed ID: 27106930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
    Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
    Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role of PRDM14 in human primordial germ cell fate revealed by inducible degrons.
    Sybirna A; Tang WWC; Pierson Smela M; Dietmann S; Gruhn WH; Brosh R; Surani MA
    Nat Commun; 2020 Mar; 11(1):1282. PubMed ID: 32152282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCL/TAL1: a multifaceted regulator from blood development to disease.
    Porcher C; Chagraoui H; Kristiansen MS
    Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
    Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
    J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-repressor CBFA2T2 regulates pluripotency and germline development.
    Tu S; Narendra V; Yamaji M; Vidal SE; Rojas LA; Wang X; Kim SY; Garcia BA; Tuschl T; Stadtfeld M; Reinberg D
    Nature; 2016 Jun; 534(7607):387-90. PubMed ID: 27281218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.